Finance
Results: 3253-3264 of 47841

Enstar Group Limited Announces Expiration and Final Results of Any And All Cash Tender Offer For Junior Subordinated Notes Due 2042

Ribo Discloses Positive Data from Vortosiran Phase 2a Trial - World's First Clinical Data on siRNA-Mediated FXI Inhibition Following Multiple Dosing in Patients with Coronary Artery Disease








